erlotinib hydrochloride has been researched along with pyrrolopyrimidine in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (pyrrolopyrimidine) | Trials (pyrrolopyrimidine) | Recent Studies (post-2010) (pyrrolopyrimidine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 92 | 1 | 77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Hoff, BH; Kaspersen, SJ; Sundby, E | 1 |
1 other study(ies) available for erlotinib hydrochloride and pyrrolopyrimidine
| Article | Year |
|---|---|
In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib.
Topics: Antineoplastic Agents; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; In Vitro Techniques; Lung Neoplasms; Ovarian Neoplasms; Pyrimidines; Pyrroles | 2015 |